Abrirá FDA puertas a LSD...?

.../...

Most people with headaches aren’t going to purchase an illegal drug. And soon, they may not have to. For the first time in four decades, the government is cracking open the door to studies looking into the medical benefits of LSD. If such studies bear fruit—and early results are promising—people like Wold may someday be able to pick up an LSD pill at their local pharmacy.

The watershed moment came last September, when the FDA approved a clinical trial on the use of LSD to treat anxiety in cancer patients. According to the Multidisciplinary Association for Psychedelic Studies (or MAPS), it was the first time since the 1960s that a medical study involving LSD was permitted by the federal government. MAPS Director Rick Doblin called it “a symbol that the psychedelic renaissance is here.”

MAPS reached its fundraising goal of $225,000 in April, and will soon run its LSD trials in Switzerland, where it’s easier to legally obtain acid. The FDA’s approval is crucial, however, because it means it will accept the data that comes out of the Swiss trials. If those results prove the drug works, the agency will then run similar tests for safety and effectiveness. Doblin thinks that because of this ruling, it’s highly possible that within 10 years LSD prescriptions for treating anxiety associated with life-threatening illnesses could be available in America.

Más...


La historia del descubrimiento del LSD ya fué tema tratado en PHARMACOSERÍAS con motivo de la muerte del Profesor Albert Hoffmann (mayo 2008). Ahora parece se produce un "revival" de esa droga (?) y de su potencial uso terapéutico en la ansiedad en pacientes oncológicos y la FDA autorizó algunos protocolos.

En mis comienzos en Sandoz (no diré el año para evitar cálculos "innecesarios") todavía LSD estaba "vivo". Recuerdo un psiquiatra de Mérida (Venezuela) que nos propuso investigarlo como desinhibidor/ facilitador en psicoterapias. Luego, al investigar (nosotros), comprobamos que su intencion de disponer del producto era "non sancta"...


Si se comercializaba (y siguió durante unos años más) DESERIL (methysergida) de estructura bastante parecida a LSD (lease bien...DeSeriL) que en otros paises (USA por ejemplo) tenía marca menos "cantante"( SANSERT).

El producto se promocionaba como profiláctico en cefaleas vasculares pero tenia serios efectos secundarios (fibrosis retroperitoneal) y fué retirado del mercado.

Tambien era rumor en ciertos ambientes lo facil de modificar la molécula y revertir (alquimia o química) en LSD. Pero era solo eso...rumor.